(Q35535222)

8 August 2017

1 reference

title

Growth hormone disorders and secondary diabetes (English)

1 reference

ORCID Public Data File 2021

8 August 2017

1 reference

author name string

Sharp PS

series ordinal

1

1 reference

PubMed ID

1445171

8 August 2017

Beshyah SA

series ordinal

2

1 reference

PubMed ID

1445171

8 August 2017

Johnston DG

series ordinal

3

1 reference

8 August 2017

1 October 1992

1 reference

Bailliere's clinical endocrinology and metabolism

8 August 2017

1 reference

8 August 2017

6

1 reference

8 August 2017

4

1 reference

8 August 2017

819-828

1 reference

On the diabetogenic effect of growth hormone in man: effects of growth hormone of glucagon and insulin secretion

8 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980168-5

7 January 2021

The effects of growth hormone on carbohydrate and lipid metabolism in the dog

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980168-5

7 January 2021

The effect of subcutaneous injection site on absorption of human growth hormone: abdomen versus thigh

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980168-5

7 January 2021

Insulin action in human adipose tissue in acromegaly

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980168-5

7 January 2021

Effects of hypopituitarism and growth hormone replacement therapy on the production and utilization of glucose in childhood.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980168-5

7 January 2021

Effects of growth hormone and of hypophysectomy on the release of insulin from rat pancreas in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980168-5

7 January 2021

The effect of growth hormone on glucose metabolism and insulin secretion in man

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980168-5

7 January 2021

Effect of growth hormone on carbohydrate and lipid metabolism

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980168-5

7 January 2021

Insulin hypersensitivity and physiological insulin antagonists

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980168-5

7 January 2021

Serum-insulin in acromegaly.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980168-5

7 January 2021

Acute Metabolic Effects of Human Growth Hormone

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980168-5

7 January 2021

Insulin secretion in acromegaly

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980168-5

7 January 2021

Peripheral glucose metabolism in acromegaly.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980168-5

7 January 2021

Acute effects of human growth hormone on insulin secretion and glucose utilization in normal and growth hormone deficient subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980168-5

7 January 2021

Effect of growth hormone on carbohydrate metabolism in hypopituitary dwarfs

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980168-5

7 January 2021

Carbohydrate tolerance and serum lipids in acromegaly before and during treatment with high dose octreotide.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980168-5

7 January 2021

Beneficial effects of growth hormone treatment in GH-deficient adults

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980168-5

7 January 2021

Increased glucose turnover and glucose cycling in acromegalic patients with normal glucose tolerance.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980168-5

7 January 2021

The plasma sugar, free fatty acid, cortisol, and growth hormone response to insulin, and the comparison of this procedure with other tests of pituitary and adrenal function. II. In patients with hypothalamic or pituitary dysfunction or anorexia nerv

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980168-5

7 January 2021

Effect of acute administration of insulin-like growth factor I in patients with Laron-type dwarfism

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980168-5

7 January 2021

Carbohydrate tolerance and insulin receptor binding in children with hypopituitarism: response after acute and chronic human growth hormone administration

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980168-5

7 January 2021

Studies on the pathogenesis of diabetes in acromegaly

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980168-5

7 January 2021

Isolated human growth hormone deficiency. III. Insulin secretion in sexual ateliotic dwarfism

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980168-5

7 January 2021

Diabetes mellitus and sexual ateliotic dwarfism: a comparative study

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980168-5

7 January 2021

Metabolic effects of acute and prolonged growth hormone excess in normal and insulin-deficient man

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980168-5

7 January 2021

Short-term effects of growth hormone on fuel oxidation and regional substrate metabolism in normal man

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980168-5

7 January 2021

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980168-5

1 reference

7 January 2021

Postoperative positive nitrogen balance with intravenous hyponutrition and growth hormone

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980168-5

7 January 2021

Growth hormone and metabolism

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980168-5

7 January 2021

Glucose tolerance and plasma immunoreactive insulin levels in acromegalics before and after selective transsphenoidal surgery.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980168-5

7 January 2021

Both human pituitary growth hormone and recombinant DNA-derived human growth hormone cause insulin resistance at a postreceptor site.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980168-5

7 January 2021

Effects of human growth hormone in men over 60 years old

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980168-5

7 January 2021

The effects of treatment with recombinant human growth hormone on body composition and metabolism in adults with growth hormone deficiency

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980168-5

7 January 2021

Changes of Carbohydrate Tolerance in Acromegaly with Progress of the Disease and in Response to Treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980168-5

7 January 2021

Plasma glucagon and insulin concentrations in acromegaly

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980168-5

7 January 2021

Effects of the infusion of insulin-like growth factor I in a child with growth hormone insensitivity syndrome (Laron dwarfism)

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980168-5

7 January 2021

Mechanism of insulin hypersensitivity in the hypophysectomized dog.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980168-5

7 January 2021

An assessment of glucose intolerance in acromegaly and its response to medical treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980168-5

7 January 2021

Growth hormone treatment of adults with growth hormone deficiency: results of a 13-month placebo controlled cross-over study

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980168-5

7 January 2021

10.1016/S0950-351X(05)80168-5

Identifiers

DOI

1 reference

8 August 2017

1 reference

PubMed ID

1445171